Purvish Parikh

3.7k total citations · 1 hit paper
21 papers, 2.6k citations indexed

About

Purvish Parikh is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Purvish Parikh has authored 21 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Purvish Parikh's work include Lung Cancer Research Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Nausea and vomiting management (2 papers). Purvish Parikh is often cited by papers focused on Lung Cancer Research Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Nausea and vomiting management (2 papers). Purvish Parikh collaborates with scholars based in India, United States and United Kingdom. Purvish Parikh's co-authors include Raghunadharao Digumarti, Joachim von Pawel, U. Gatzemeier, Mauro Zukin, Tuncay Göksel, Katherine P. Sugarman, Christian Manegold, Filippo de Marinis, Anders Mellemgaard and Bonne Biesma and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Purvish Parikh

20 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

2008 2.5k citations Giorgio V. Scagliotti, Purvish Parikh et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Purvish Parikh India	9	2.1k	1.8k	521	412	186	21	2.6k
Miloš Pešek Czechia	21	1.7k 0.8×	1.6k 0.9×	650 1.2×	408 1.0×	133 0.7×	110	2.4k
Daniel T. Milton United States	16	1.9k 0.9×	1.6k 0.9×	587 1.1×	383 0.9×	125 0.7×	27	2.4k
Patrick Peterson United States	21	2.2k 1.0×	1.8k 1.0×	472 0.9×	310 0.8×	166 0.9×	55	2.6k
Eckart Laack Germany	23	2.2k 1.1×	2.0k 1.1×	619 1.2×	408 1.0×	195 1.0×	61	3.0k
Cesare Gridelli Italy	18	2.4k 1.1×	2.1k 1.2×	527 1.0×	270 0.7×	179 1.0×	37	2.9k
Mauro Zukin Brazil	13	2.8k 1.3×	2.4k 1.3×	748 1.4×	519 1.3×	207 1.1×	38	3.5k
Isabel Bover Spain	13	1.3k 0.6×	1.3k 0.7×	401 0.8×	247 0.6×	204 1.1×	48	2.1k
E.H. Tan Singapore	8	2.0k 0.9×	1.8k 1.0×	544 1.0×	367 0.9×	260 1.4×	23	2.4k
Annetta Krebs United States	8	1.9k 0.9×	2.0k 1.1×	723 1.4×	395 1.0×	131 0.7×	8	2.8k
Atsushi Horiike Japan	28	1.3k 0.6×	1.3k 0.7×	604 1.2×	391 0.9×	127 0.7×	107	2.1k

Countries citing papers authored by Purvish Parikh

Since Specialization

Citations

This map shows the geographic impact of Purvish Parikh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Purvish Parikh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Purvish Parikh more than expected).

Fields of papers citing papers by Purvish Parikh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Purvish Parikh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Purvish Parikh. The network helps show where Purvish Parikh may publish in the future.

Co-authorship network of co-authors of Purvish Parikh

This figure shows the co-authorship network connecting the top 25 collaborators of Purvish Parikh. A scholar is included among the top collaborators of Purvish Parikh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Purvish Parikh. Purvish Parikh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Parikh, Purvish, Gopal Sharma, Raja Pramanik, et al.. (2024). Management of Metastatic Colorectal Cancer (mCRC): Real-World Recommendations. SHILAP Revista de lepidopterología. 13(4). 287–295.

Parikh, Purvish, et al.. (2023). Unmet Needs in Geriatric Oncology. SHILAP Revista de lepidopterología. 12(2). 221–227. 3 indexed citations

Scagliotti, Giorgio V., Purvish Parikh, Joachim von Pawel, et al.. (2023). Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 41(14). 2458–2466. 17 indexed citations

Patel, Brijesh, Daniel Addison, Lauren A. Baldassarre, et al.. (2021). Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience. Open Heart. 8(2). e001849–e001849. 11 indexed citations

Parikh, Purvish, et al.. (2020). Violence against Health Care Professionals and Facilities—Local Insights about a Global Malady. South Asian Journal of Cancer. 9(4). 257–260. 3 indexed citations

Parikh, Purvish, et al.. (2019). Mediclaim insurance challenges and solutions – Doctors supporting patients: A Medic LAWgic initiative. Indian Journal of Medical Sciences. 71. 22–27. 1 indexed citations

Krishnamurthy, Arvind, et al.. (2018). Clinical utility of immunohistochemistry using the novel anti-BRAF V600E antibody (clone RM8) for detection of the BRAF V600E mutant protein in papillary thyroid cancers. 3(1). 28–28. 4 indexed citations

Malhotra, Hemant, et al.. (2017). ED02.03 Palliative Care in India. Journal of Thoracic Oncology. 12(1). S22–S24. 1 indexed citations

Patil, Vijay, Vanita Noronha, Amit Joshi, et al.. (2017). Survey of Implementation of Antiemetic Prescription Standards in Indian Oncology Practices and Its Adherence to the American Society of Clinical Oncology Antiemetic Clinical Guideline. Journal of Global Oncology. 3(4). 346–359. 4 indexed citations

10.

Shridhar, Krithiga, Preetha Rajaraman, Shravani Koyande, et al.. (2016). Trends in mouth cancer incidence in Mumbai, India (19952009): An age-period-cohort analysis. Cancer Epidemiology. 42. 66–71. 13 indexed citations

11.

Bakshi, Ashish, et al.. (2012). Importance of dose intensity in treatment of advanced nonsmall cell lung cancer in the elderly. SHILAP Revista de lepidopterología. 1(1). 9–15. 4 indexed citations

12.

Cortes, Jörge E., Raghunadharao Digumarti, Purvish Parikh, et al.. (2009). Safety and Efficacy of Subcutaneous-Administered Omacetaxine Mepesuccinate in Chronic Myeloid Leukemia (CML) Patients Who Are Resistant or Intolerant to Two or More Tyrosine Kinase Inhibitors – Results of A Multicenter Phase 2/3 Study.. Blood. 114(22). 861–861. 28 indexed citations

13.

Scagliotti, Giorgio V., Purvish Parikh, Joachim von Pawel, et al.. (2008). Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 26(21). 3543–3551. 2487 indexed citations breakdown →

14.

Jain, Preetesh, et al.. (2008). Neoadjuvant chemotherapy or chemoradiotherapy in head and neck cancer. Indian Journal of Cancer. 45(3). 83–83. 12 indexed citations

15.

Mohan, Adithi, et al.. (2006). The study of c-Src kinase and pStat3 protein expression in retinoblastoma. Experimental Eye Research. 83(4). 736–740. 5 indexed citations

16.

Arora, B, Purna Kurkure, & Purvish Parikh. (2005). Childhood cancers: perspectives in India.. PubMed. 103(9). 479–82. 11 indexed citations

17.

Gupta, Sudeep, et al.. (2005). Acute leukaemia presenting as vulvar ulcers in an adolescent girl. Australian and New Zealand Journal of Obstetrics and Gynaecology. 45(6). 536–537. 3 indexed citations

18.

Nadkarni, Jayshree J., Vipul Rathore, Kishore Amin, et al.. (1998). Expression of Adhesion Molecules in B-cell Chronic Lymphocytic Leukaemia: an Analysis in Lymphoid Compartments - Peripheral Blood, Bone Marrow and Lymph Node. Cancer Biotherapy and Radiopharmaceuticals. 13(4). 269–274. 9 indexed citations

19.

Parikh, Purvish, et al.. (1998). Abnormal levels of proinflammatory cytokines in serum and monocyte cultures from patients with chronic myeloid leukemia in different stages, and their role in prognosis. Hematological Oncology. 16(4). 143–154. 7 indexed citations

20.

Parikh, Purvish, et al.. (1988). A prospective, randomized double-blind trial comparing metoclopramide alone with metoclopramide plus dexamethasone in preventing emesis induced by high-dose cisplatin. Cancer. 62(10). 2263–2266. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact